ENTITY
Ocumension Therapeutics

Ocumension Therapeutics (1477 HK)

30
Analysis
Health CareChina
Ocumension Therapeutics operates as a pharmaceutical company. The Company focuses on identifying, developing, and commercializing ophthalmic therapies. Ocumension Therapeutics serves customers in the United States and China.
more
Refresh
29 Jun 2020 16:48

Ocumension (欧康维视) IPO: Hot Deal, Small Float

Ocumension Therapeutics, a leading ophthalmic pharmaceutical platform company with a focus on first-in-class or best-in-class ophthalmic...

Logo
406 Views
Share
28 Jun 2020 21:38

Ocumension Therapeutics IPO Initiation: Look into My Eyes

Ocumension Therapeutics (1764324D CH) is a China-based ophthalmic pharmaceutical company dedicated to identifying, developing and commercializing...

Logo
403 Views
Share
22 Jun 2020 09:57

Ocumension (欧康维视) Pre-IPO: All Ready for a Great Listing Except a Block Buster

Ocumension Therapeutics, a leading ophthalmic pharmaceutical platform company with a focus on first-in-class or best-in-class ophthalmic therapies,...

Logo
443 Views
Share
x